Greater Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache
GONPRFCEH
Efficacy of Greater Occipital Nerve Pulsed Radiofrequency Treatment at C2 Level in Cervicogenic Headache
GONPRFCEH
Efficacy of Greater Occipital Nerve Pulsed Radiofrequency Treatment at C2 Level in Cervicogenic Headache
Sponsor study identifier
Secondary identifiers
OTHER · Bilkent Ankara City Hospital
interventional
25
1 country
1
Study Start
March 1, 2023
Actual (reported)Primary Completion
January 1, 2024
Actual (reported)Study Completion
December 1, 2024
Actual (reported)The effect of GON PRF treatment applied with USG-guided proximal technique in patients who do not respond to conservative treatments for cervicogenic headache
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2023
Actual (reported)January 1, 2024
Actual (reported)December 1, 2024
Actual (reported)January 2, 2025
Actual (reported)January 8, 2025
Actual (reported)Visual Analog Scale
Average headache severity, maximum headache severity, number of headache days (monthly) measured with a visual analog scale (VAS; 10-point VAS scoring, 0 being no pain and 10 being the highest pain intensity that can be tolerated)
3 months
According to the International Classification of Headache Disorders (ICHD)-III diagnostic criteria, patients diagnosed with cervicogenic headache will undergo a proximal technique C2 level greater occipital nerve (GON) diagnostic block under ultrasound (USG) guidance, and patients with a positive response (≥50% reduction in pain or positive effect) will receive GON-PRF treatment with the same technique. This study mainly aims to evaluate the clinical efficacy and safety of GON PRF treatment applied at the C2 level under USG guidance in cervicogenic headache during the follow-up period. Our secondary aim is to determine the effects of the GON PRF treatment we applied on the analgesic drug consumption, daily life activities and sleep of the volunteers, how they generally perceive this treatment and whether there is a need for any additional treatment.
GON PRF treatment, which we apply by imaging the target nerve and surrounding structures with the proximal technique (at C2 level) under USG guidance in patients who do not respond to conservative treatments for cervicogenic headache.
Ultrasound-guided pulsed radiofrequency treatment of the greater occipital nerve at the C2 level
Health Sciences University, Ankara Bilkent City Hospital
Ankara, Cankaya, 06800, Turkey (Türkiye)
Gabrhelik T, Michalek P, Adamus M. Pulsed radiofrequency therapy versus greater occipital nerve block in the management of refractory cervicogenic headache - a pilot study. Prague Med Rep. 2011;112(4):279-87.
25 participants (actual enrollment reported by the registry).
First Submitted
January 2, 2025
First Posted
January 8, 2025
Study Start
March 1, 2023
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
January 1, 2024
Actual (reported)Study Completion
December 1, 2024
Actual (reported)Last Updated
March 2, 2026
Record last verified: 2026-02
I dont want to.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: